Cargando…

Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma

BACKGROUND: The prognostic factors of skull base chordoma associated with outcomes of patients after surgery remain inadequately identified. This study was designed to identify a novel prognostic factor for patients with skull base chordoma. METHOD: Using a proteomic technique, the tumor biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yutao, Li, Mingxuan, Xiong, Yujia, Gui, Songbai, Bai, Jiwei, Zhang, Yazhuo, Li, Chuzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440958/ https://www.ncbi.nlm.nih.gov/pubmed/34540668 http://dx.doi.org/10.3389/fonc.2021.698497

Ejemplares similares

High systemic inflammation score is associated with adverse survival in skull base chordoma
por: Li, Mingxuan, et al.
Publicado: (2022)

Endoscopic Endonasal Surgical Strategy for Skull Base Chordomas Based on Tumor Growth Directions: Surgical Outcomes of 167 Patients During 3 Years
por: Bai, Jiwei, et al.
Publicado: (2021)

PALB2 as a factor to predict the prognosis of patients with skull base chordoma
por: Xiong, Yujia, et al.
Publicado: (2022)

High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma
por: Li, Mingxuan, et al.
Publicado: (2021)

Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients
por: Li, Mingxuan, et al.
Publicado: (2021)

Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5
por: Li, Mingxuan, et al.
Publicado: (2021)

Prognostic Value of Cumulative Score Based on Preoperative Fibrinogen and Albumin Level in Skull Base Chordoma
por: Li, Mingxuan, et al.
Publicado: (2020)

Mean platelet volume and platelet distribution width serve as prognostic biomarkers in skull base chordoma: a retrospective study
por: Li, Mingxuan, et al.
Publicado: (2020)

Mid-term follow-up surgical results in 284 cases of clival chordomas: the risk factors for outcome and tumor recurrence
por: Bai, Jiwei, et al.
Publicado: (2021)

Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival
por: Bai, Jiwei, et al.
Publicado: (2021)

LncRNA and mRNA expression profiles reveal the potential roles of lncRNA contributing to regulating dural penetration in clival chordoma
por: Bai, Jiwei, et al.
Publicado: (2020)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomas
por: Zhai, Yixuan, et al.
Publicado: (2022)

Emotional Problems, Quality of Life and Symptom Burden in Patients with Chordoma
por: Wu, Youtu, et al.
Publicado: (2023)

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway
por: Liu, Qian, et al.
Publicado: (2023)

Application of endoscopic endonasal approach in skull base surgeries: summary of 1886 cases in a single center for 10 consecutive years
por: Li, Chuzhong, et al.
Publicado: (2020)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility
por: Yepes, Sally, et al.
Publicado: (2021)

The Functional Reorganization of Language Network Modules in Glioma Patients: New Insights From Resting State fMRI Study
por: Jin, Lu, et al.
Publicado: (2021)

The role of Gamma Knife radiosurgery in the management of skull base chordoma
por: Wang, Kuanyu, et al.
Publicado: (2023)

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
por: Li, Ping, et al.
Publicado: (2016)

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
por: Gao, Hua, et al.
Publicado: (2015)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
por: Long, Cheng, et al.
Publicado: (2021)

Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas
por: Yuan, Taoyang, et al.
Publicado: (2020)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Prognostic Utility of Optical Coherence Tomography for Visual Outcome After Extended Endoscopic Endonasal Surgery for Adult Craniopharyngiomas
por: Qiao, Ning, et al.
Publicado: (2022)

Hemorrhagic Skull Base Chordoma Presenting As Chordoma Apoplexy
por: Uysal, Ece, et al.
Publicado: (2021)

Expanded Transsphenoidal Trans-Lamina Terminalis Approach to Tumors Extending Into the Third Ventricle: Technique Notes and a Single Institute Experience
por: Cao, Lei, et al.
Publicado: (2021)

Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience
por: Nie, Menglin, et al.
Publicado: (2022)

Surgical resection of unilateral thalamic tumors in adults: approaches and outcomes
por: Cao, Lei, et al.
Publicado: (2015)

Endoscopic Endonasal Transsphenoidal Surgery for Recurrent Craniopharyngiomas
por: Feng, Zhenguang, et al.
Publicado: (2022)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Ectopic Recurrence of Skull Base Chordoma after Proton Therapy
por: Santegoeds, René G. C., et al.
Publicado: (2022)

SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
por: Righi, Alberto, et al.
Publicado: (2023)

Proton Therapy for Skull-Base Chordomas and Chondrosarcomas: Initial Results From the Beaumont Proton Therapy Center
por: Parzen, Jacob S, et al.
Publicado: (2021)

Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma
por: Teng, Chubei, et al.
Publicado: (2021)

The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor
por: Nie, Ding, et al.
Publicado: (2021)

Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cells☆
por: Bai, Jiwei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bc6j0p7gj8kikar1u14bnhp868